Evaluation of cytokine levels using QuantiFERON-TB Gold Plus in patients with active tuberculosis
- 22 February 2020
- journal article
- research article
- Published by Elsevier BV in Journal of Infection
- Vol. 80 (5), 547-553
- https://doi.org/10.1016/j.jinf.2020.02.007
Abstract
No abstract availableFunding Information
- AMED (JP18fk0410016 h0001)
- JSPS (18K08461)
This publication has 39 references indexed in Scilit:
- Dried plasma spots in the diagnosis of tuberculosis: IP-10 release assay on filter paperEuropean Respiratory Journal, 2013
- Evaluation of the Diagnostic Potential of IP-10 and IL-2 as Biomarkers for the Diagnosis of Active and Latent Tuberculosis in a BCG-Vaccinated PopulationPLOS ONE, 2012
- Biochemical and Molecular Characterization of the Gentisate Transporter GenK in Corynebacterium glutamicumPLOS ONE, 2012
- Functional Capacity of Mycobacterium tuberculosis-Specific T Cell Responses in Humans Is Associated with Mycobacterial LoadThe Journal of Immunology, 2011
- Interferon- release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysisEuropean Respiratory Journal, 2010
- Serum IP-10 as a Biomarker of Human Rhinovirus Infection at Exacerbation of COPDSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2010
- Comparison of T-Cell Interferon-γ Release Assays for Mycobacterium tuberculosis-Specific Antigens in Patients with Active and Latent TuberculosisLung, 2010
- Interferon- release assays for the diagnosis of active tuberculosis: sensible or silly?European Respiratory Journal, 2009
- Host markers in Quantiferon supernatants differentiate active TB from latent TB infection: preliminary reportBMC Pulmonary Medicine, 2009
- Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosisEuropean Respiratory Journal, 2008